RecruitingACTRN12615000708550

Analgesic efficacy of paravertebral dexmedetomidine in children undergoing renal surgery

In children undergoing renal surgery, does paravertebral dexmedetomidine added to bupivacaine, compared to paravertebral bupivacaine only, reduce postoperative opioid consumption?


Sponsor

diab fuad hetta

Enrollment

80 participants

Start Date

Sep 1, 2015

Study Type

Interventional

Conditions

Summary

Evaluation of postoperative analgesic efficacy of paravertebral dexmedetomidine when added to bupivacaine in pediatric patients undergoing renal surgery


Eligibility

Sex: Both males and femalesMin Age: 3 YearssMax Age: 12 Yearss

Inclusion Criteria2

  • -Renal surgery
  • -patients with physical status American Society of Anaesthesiologist (ASA) I , II and III

Exclusion Criteria2

  • -contraindication to PVB (infection at site of injection, coagulopathy, vertebral anomalies)
  • - allergy to drugs used in the study

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

After induction of anesthesia and before skin incision, for group PD, with the patient in the lateral decubitus position and the operated side facing upwards. Needle insertion will be made at an eas

After induction of anesthesia and before skin incision, for group PD, with the patient in the lateral decubitus position and the operated side facing upwards. Needle insertion will be made at an easily palpated single low thoracic level (Th10–12) lateral to the spinal process. The distance from the midline will be (approximating the distance between the patient’s two adjacent spinous processes). A 22 G Tuohy needle will be inserted perpendicularly to the skin in all planes until contact with the transverse process. The needle will be then advanced under or over the transverse process and after piercing the costo-transverse ligament, the paravertebral space was identified by loss of resistance to air. After careful aspiration, a single bolus dose of 0.5 ml / kg of Bupivacaine 0.25% and 1.5 mic /kg dexmedetomidine will be injected.


Locations(1)

Egypt

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12615000708550